Connect
GO

« All Blogs
Feed

Everything you need to know about ADD/ADHD in the news and media, brought to you by the editors at ADDitude.

« Recent Blog Posts

Archives: April 2016

posted: Thursday April 28th - 2:36pm

ADHD More Common in Children with Vision Problems

After analyzing a nationally representative sample of children, researchers found that children with vision problems not correctable with glasses or contacts may be twice as likely to have ADHD.

April 28, 2016 A study, published in the journal Optometry and Vision Science sought to compare the incidence of ADHD in children who can see normally, and those with vision problems which cannot be corrected with glasses or contacts. Examples of this type of vision problems include disorders of eye alignment (crossed eyes) or eye movement (nystagmus). They found that, after adjusting for other factors known to...
Continue Reading »
posted: Thursday April 28th - 11:35am

Plastic Softening Phthalates Linked to ADHD in Children Treated in Pediatric Intensive Care Units

Phthalates are prohibited from use in kids’ toys because of toxic effects, but remain in medical devices such as plastic tubes and catheters. A new study finds that children exposed to these chemicals during hospitalization had a higher risk of developing ADHD.

April 28, 2016 Phthalates are a family of chemicals that are used to make rubber-based materials soft and pliable. They are found in vinyl, plastic bottles, shower curtains, raincoats, and are also used to make personal-care products, air fresheners, and shampoos. Physicians have suspected a link between exposure and ADHD for many years. Six types of phthalates are banned for use in children’s toys and children’s child...
Continue Reading »
posted: Thursday April 28th - 10:07am

ADHD Drug Atomoxetine Does Not Increase Risk for Suicidal Events

The FDA has warned that atomoxetine might cause greater incidence of suicidal thoughts or behavior for over a decade. New research by the University of Florida College of Pharmacy finds no confirming evidence for the warning.

April 28, 2016 Atomoxetine, a non-stimulant medication for ADHD, known by its brand name Strattera, has carried a black box warning from the FDA since 2005. After reviewing 12 clinical trials involving approximately 2,200 children taking Strattera, and finding one attempted suicide and five suicidal events within 32 days of treatment, the agency warned doctors and parents that Strattera could cause “agitation, irritability, suicidal thinking or behaviors,...
Continue Reading »
posted: Wednesday April 27th - 12:43pm

Study Suggests PS-Omega-3 Medical Food May Reduce ADHD Symptoms

Two-thirds of study participants taking PS-Omega-3 medical food experienced a reduction in symptoms, and one-third were able to lower their ADHD medication dosage.

Wednesday, April 27, 2016 PS-Omega-3 is an effective non-drug treatment for ADHD — this is the finding of a retrospective study, showcased at the National ADHD Conference on April 7-8, 2016, in Tel Aviv, Israel. PS-Omega-3 is VAYA Pharma’s proprietary composition of phosphatidylserine, a negatively charged aminophspholipid (type of fat) found throughout the body and brain, bonded to non-drug treatment for Omega-3 fatty acids. Vayarin, a prescription medical...
Continue Reading »
posted: Tuesday April 26th - 10:38am

Video Game and Social Media Addiction Tied to ADHD

According to a new study, individuals with ADHD, anxiety, and depression are more likely to show signs of technology addiction.

Tuesday, April 26, 2016 Researchers at the University of Bergen, Norway, have found a positive, significant correlation between addictive use of technology and comorbid psychiatric disorders including ADHD, anxiety, depression, and obsessive-compulsive disorder (OCD). According to a study published in the March 2016 issue of the journal Psychology of Addictive Behaviors of the American Psychological Association, the results of large-scale, cross-sectional study suggest that men with symptoms...
Continue Reading »
posted: Thursday April 21st - 3:09pm

The First Liquid Amphetamine for ADHD: Broadening the Menu of Choices for Treating Attention Deficit

Recently released Dyanavel XR gives families living with ADHD a new option in the search for optimal treatment.

Posted on April 21, 2016 Tris Pharma announced on April 19, 2016, that it was releasing a new liquid ADHD medication, known as Dyanavel XR, for the treatment of attention deficit in patients ages six and above. The long-acting formulation is suitable for families seeking once-daily doses, the company said in a press release — particularly for young children who struggle to swallow pills. The medication, the first...
Continue Reading »
posted: Monday April 11th - 1:29pm

Good News: Some Adults with ADHD Are Actually More Resilient to Depression

Earlier treatment and CBT techniques may help explain why some ADHDers don’t develop depression.

Published April 11, 2016 ADHD has long been associated with a higher risk of depression and other mood disorders, but not every adult with ADHD suffers from depression, In fact, some are highly resilient to the condition. A team from the University of Richmond is working to figure out why this is. They conducted a study to try to identify any factors that contribute to depression —...
Continue Reading »
« ADHD News Feed's blog

« All Blogs

 

Archives

Copyright © 1998 - 2016 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 108 West 39th Street, Suite 805, New York, NY 10018